Globus Medical (GMED) Non-Current Deferred Tax Liability (2011 - 2026)

Globus Medical (GMED) has reported Non-Current Deferred Tax Liability for 16 consecutive years, with $42.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Deferred Tax Liability rose 73.52% year-over-year to $42.3 million; the trailing twelve-month figure through Jun 2026 stood at $42.3 million (up 73.52% YoY), and the FY2025 full-year result was $23.8 million, down 0.56% from the prior year.
• Non-Current Deferred Tax Liability advanced to $42.3 million in Q2 2026 per GMED's latest filing, from $24.7 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $132.2 million in Q3 2023 and bottomed at $1.4 million in Q1 2023.
• Historically, Non-Current Deferred Tax Liability has averaged $28.7 million across 5 years, with a median of $23.8 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Non-Current Deferred Tax Liability soared 8277.12% in 2023, then tumbled 94.35% in 2024.
• Over 5 years, Non-Current Deferred Tax Liability stood at $1.8 million in 2022, then soared by 4645.42% to $84.4 million in 2023, then slumped by 71.7% to $23.9 million in 2024, then retreated by 0.56% to $23.8 million in 2025, then surged by 78.24% to $42.3 million in 2026.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $42.3 million, $24.7 million, and $23.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.